Jazz Pharmaceuticals Plc(NASDAQ : JAZZ)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Loading JAZZ News...
Health Technology » Pharmaceuticals Other
|SHPG||Shire PLC Sponsored ADR||-7.91%||166.03||9.9%||$682.82m|
|VRX||Valeant Pharmaceuticals International, Inc.||-8.85%||20.28||7.1%||$590.12m|
|PRGO||Perrigo Co. Plc||-4.44%||90.97||4.0%||$246.55m|
|ENDP||Endo International Plc||-6.25%||14.85||4.1%||$131.38m|
|JAZZ||Jazz Pharmaceuticals Plc||-4.90%||137.90||2.7%||$122.88m|
|ICPT||Intercept Pharmaceuticals, Inc.||-7.35%||142.92||13.8%||$89.19m|
|HZNP||Horizon Pharma plc||-6.82%||16.25||9.7%||$64.47m|
|UTHR||United Therapeutics Corporation||-3.01%||102.11||19.5%||$61.35m|
|GWPH||GW Pharmaceuticals PLC Sponsored ADR||-6.54%||83.31||12.2%||$37.71m|
Jazz Pharmaceuticals Plc operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products. The company has a diverse portfolio of products in the areas of narcolepsy, oncology, pain and psychiatry. Its product portfolio includes: XYREM, ERWINAZETM, PRIALT, intrathecal infusion, FAZACLO and LUVOX CR. The company was founded on January 18, 2012 and is headquartered in Dublin, Ireland.